LLY

755.22

+3.01%↑

JNJ

153.86

-0.07%↓

UNH

378.43

-0.51%↓

ABBV

189.92

+3.08%↑

ABT

131.96

-0.98%↓

LLY

755.22

+3.01%↑

JNJ

153.86

-0.07%↓

UNH

378.43

-0.51%↓

ABBV

189.92

+3.08%↑

ABT

131.96

-0.98%↓

LLY

755.22

+3.01%↑

JNJ

153.86

-0.07%↓

UNH

378.43

-0.51%↓

ABBV

189.92

+3.08%↑

ABT

131.96

-0.98%↓

LLY

755.22

+3.01%↑

JNJ

153.86

-0.07%↓

UNH

378.43

-0.51%↓

ABBV

189.92

+3.08%↑

ABT

131.96

-0.98%↓

LLY

755.22

+3.01%↑

JNJ

153.86

-0.07%↓

UNH

378.43

-0.51%↓

ABBV

189.92

+3.08%↑

ABT

131.96

-0.98%↓

Kodu・Aktsiate loetelu・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Suletud

SektorTervishoid

35.61 4.64

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

34.18

Max

35.73

Põhinäitajad
By Trading Economics
Sissetulek	3.4M 49M
Müük	15M 201M
P/E Sektori keskmine	12.08 54.379
Aktsiakasum	1.08
Kasumimarginaal	24.582
Töötajad	268
EBITDA	-6.2M 66M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+49.78% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	5. aug 2025

Turustatistika
By TradingEconomics
Turukapital	-209M 1.7B
Eelmine avamishind	30.97
Eelmine sulgemishind	35.61

Uudiste sentiment

By Acuity

50%

198 / 382 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

29.8 / N/A Toetus ja vastupanu

Harmony Biosciences Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

12. mai 2025, 22:34 UTC

Omandamised, ülevõtmised, äriostud

Ampol to Sell Retail Electricity Businesses in Australia, New Zealand

12. mai 2025, 23:48 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

12. mai 2025, 23:46 UTC

Market Talk

Nikkei Likely to Rise on Hopes for Improving U.S.-China Trade Relations -- Market Talk

12. mai 2025, 23:34 UTC

Market Talk

Trade Deal Lowers US Recession Risks to 35% -- Market Talk

12. mai 2025, 23:21 UTC

Market Talk

US-China Trade Deal Still Risks Stagflation; Supply Chain Disruption -- Market Talk

12. mai 2025, 22:54 UTC

Market Talk

Australian Treasurer Warns Uncertainty Will Still Dominate Markets -- Market Talk

12. mai 2025, 22:43 UTC

Tulu

Telefonica Brasil 1Q EPS BRL0.65 >VIV

12. mai 2025, 22:14 UTC

Peamised uudised

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- 2nd Update

12. mai 2025, 22:08 UTC

Omandamised, ülevõtmised, äriostud

Ampol Expects Replacement-Cost Ebitda Uplift by Run Rate at End-2025 of Around A$30 Million/Year

12. mai 2025, 22:08 UTC

Omandamised, ülevõtmised, äriostud

Ampol Expects Pretax Proceeds of Around A$65 Million From Transactions

12. mai 2025, 22:07 UTC

Omandamised, ülevõtmised, äriostud

Ampol to Sell Australia Retail Electricity Business for Nominal Sum

12. mai 2025, 22:07 UTC

Omandamised, ülevõtmised, äriostud

Ampol to Sell Australia Retail Electricity Business to AGL

12. mai 2025, 22:06 UTC

Omandamised, ülevõtmised, äriostud

Meridian to Take on Flick, Z Energy Branded Electricity Customers

12. mai 2025, 22:06 UTC

Omandamised, ülevõtmised, äriostud

Meridian Energy to Buy Business From Ampol for NZ$70 Million

12. mai 2025, 22:05 UTC

Omandamised, ülevõtmised, äriostud

Ampol to Sell New Zealand Electricity Retailing Businesses to Meridian Energy

12. mai 2025, 22:04 UTC

Omandamised, ülevõtmised, äriostud

Ampol to Sell Retail Electricity Businesses in Australia, New Zealand

12. mai 2025, 21:15 UTC

Peamised uudised

Republican Tax Plan Boosts SALT Deduction, Ends Green-Energy Breaks -- 2nd update -- WSJ

12. mai 2025, 21:01 UTC

Tulu

Constellation Software 1Q Rev $2.65B >CSU.T

12. mai 2025, 21:01 UTC

Tulu

Constellation Software 1Q Net $115M >CSU.T

12. mai 2025, 21:01 UTC

Tulu

Constellation Software 1Q EPS $5.44 >CSU.T

12. mai 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

12. mai 2025, 20:50 UTC

Market Talk

Tulu

Basic Materials Roundup: Market Talk

12. mai 2025, 20:44 UTC

Peamised uudised

Trade Thaw Sparks Stock Rally, Leaves Wall Street Cautious -- WSJ

12. mai 2025, 20:31 UTC

Peamised uudised

How to Think About the Stock Market When Earnings Guidance Becomes Meaningless -- Heard on the Street -- UPDATED -- WSJ

12. mai 2025, 20:24 UTC

Tulu

Energy Vault Holdings: Encouraging News on China/U.S. Tariff Pause, Pending Final Positive Resolution and Timing >NRGV

12. mai 2025, 20:24 UTC

Tulu

Energy Vault Holdings: No Change to Current Guidance, With Potential Rev Upside on Accelerated U.S. Battery Deliveries in 2025 >NRGV

12. mai 2025, 20:24 UTC

Peamised uudised

Republican Tax Plan Boosts SALT Deduction, Ends Green-Energy Breaks -- WSJ

12. mai 2025, 20:22 UTC

Omandamised, ülevõtmised, äriostud

Spirit AeroSystems Holdings: IRS Rules That Sale to Boeing Will Qualify as a Reorganization Under Section 368(a)(1)(B)

12. mai 2025, 20:15 UTC

Tulu

Rigetti Computing Reports Earnings. How the Company Takes a Different Approach to Quantum. -- Barrons.com

12. mai 2025, 20:10 UTC

Tulu

Blink Charging 1Q Rev $20.8M >BLNK

Võrdlus sarnastega

Hinnamuutus

Harmony Biosciences Holdings Inc Prognoos

Hinnasiht

By TipRanks

49.78% tõus

12 kuu keskmine prognoos

Keskmine 51 USD 49.78%

Kõrge 70 USD

Madal 31 USD

Põhineb 7 Wall Streeti analüütiku instrumendi Harmony Biosciences Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

7 ratings

Osta

Hoia

Müü

Põhineb 7 analüütiku instrumendi Harmony Biosciences Holdings Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

29.8 / N/AToetus ja vastupanu

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

198 / 382 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.